Established by ADQ, an active sovereign investor focused on critical infrastructure and global supply chains, Arcera is ...

Belgium-based Agomab Therapeutics today announced positive data from 103 participants completing 12 weeks of treatment in the ...

Sofinnova Partners, a European life sciences venture capital firm based in Paris, London and Milan, today announced the close ...

The European Federation of Pharmaceuticals Industries and Associations (EFPIA) and Vaccine Europe (VE) are calling for clear, ...

Export Barbados (BIDC) and EarlyHealth Group (EHG), headquartered in Dubai, United Arab Emirates, have signed a Letter of Intent to jointly establish EarlyHealth City Barbados, a $200 million ...

Last week saw the end of the bidding war for Metsera, with the company accepting an improved offer from Pfizer and counter ...

The European Medicines Agency’s EMA’s human medicines committee (CHMP) recommended seven novel medicines for approval at its ...

Between the US government shutdown, crippling international tariffs, debilitating funding cuts to critical research, and the ...

Gate Bioscience has raised $65 million in an oversubscribed series B to advance its first molecular gate candidates, a novel ...

US medtech firm Terumo Blood and Cell Technologies has appointed Liza Loidolt as general manager of its cell and gene therapy ...

Merck & Co has struck a $9.2 billion deal to acquire biotechnology company Cidara Therapeutics in a move that bolsters the US ...

UK-based life sciences venture capital firm Medicxi today announced the closing of Medicxi V, a 500 million-euros ($579.5 ...